Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Midas Pharma
Ingelheim am Rhein, Rheinland-Pfalz, Germanymidas-pharma.com ↗
- Ownership
- Private
- Employees
- ~300
- Development stage
- Commercial
01
Overview
No clinical results published—Midas operates mainly as a service provider/CDMO supporting client pipelines from early development through commercial supply.
- Therapeutic areas
- Other
- Modalities
- Small moleculesBiologics/biopharmaceuticals (proteins, gene therapeutics)Medical devices/combination productsGenerics
- Industry
- Drug Discovery Services
02
Partnerships
Gerresheimer – collaboration on Gx Inbeneo® autoinjector platform for combination productsNumerous undisclosed partners globally due to B2B business model.
Beyond the preview
Go deeper on Midas Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Midas Pharma.